Kevin Caliendo
Stock Analyst at UBS
(4.51)
# 279
Out of 5,134 analysts
203
Total ratings
73%
Success rate
12.07%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Maintains: Neutral | $190 → $210 | $205.49 | +2.19% | 17 | Feb 11, 2026 | |
| ALGN Align Technology | Maintains: Neutral | $175 → $185 | $187.22 | -1.19% | 20 | Feb 5, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $17 → $16 | $12.44 | +28.62% | 13 | Feb 3, 2026 | |
| NVST Envista Holdings | Maintains: Neutral | $22 → $25 | $28.07 | -10.94% | 5 | Feb 3, 2026 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $18 → $21 | $20.59 | +1.99% | 9 | Jan 14, 2026 | |
| MDLN Medline | Initiates: Buy | $48 | $46.16 | +3.99% | 1 | Jan 12, 2026 | |
| CVS CVS Health | Maintains: Buy | $96 → $97 | $78.20 | +24.04% | 11 | Dec 10, 2025 | |
| SOLV Solventum | Maintains: Neutral | $77 → $79 | $73.73 | +7.15% | 2 | Nov 10, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $7.04 | +42.05% | 6 | Nov 7, 2025 | |
| COR Cencora | Maintains: Buy | $380 → $415 | $359.97 | +15.29% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.25 → $4 | $2.22 | +80.18% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $920 → $980 | $946.47 | +3.54% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $220 | $225.58 | -2.47% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $378 → $430 | $289.09 | +48.74% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $320 | $276.67 | +15.66% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $135.68 | +25.29% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $70 | $77.21 | -9.34% | 6 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $2.72 | +451.47% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $5.53 | +62.75% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $290.71 | +34.15% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $184.99 | +35.14% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $41.23 | +91.61% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $344.78 | +66.77% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $243.33 | -26.03% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $4.56 | +1,478.95% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $34.41 | -68.03% | 4 | May 4, 2021 |
Quest Diagnostics
Feb 11, 2026
Maintains: Neutral
Price Target: $190 → $210
Current: $205.49
Upside: +2.19%
Align Technology
Feb 5, 2026
Maintains: Neutral
Price Target: $175 → $185
Current: $187.22
Upside: -1.19%
DENTSPLY SIRONA
Feb 3, 2026
Maintains: Buy
Price Target: $17 → $16
Current: $12.44
Upside: +28.62%
Envista Holdings
Feb 3, 2026
Maintains: Neutral
Price Target: $22 → $25
Current: $28.07
Upside: -10.94%
Alignment Healthcare
Jan 14, 2026
Maintains: Neutral
Price Target: $18 → $21
Current: $20.59
Upside: +1.99%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $48
Current: $46.16
Upside: +3.99%
CVS Health
Dec 10, 2025
Maintains: Buy
Price Target: $96 → $97
Current: $78.20
Upside: +24.04%
Solventum
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $73.73
Upside: +7.15%
LifeStance Health Group
Nov 7, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $7.04
Upside: +42.05%
Cencora
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $359.97
Upside: +15.29%
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.22
Upside: +80.18%
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $946.47
Upside: +3.54%
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $225.58
Upside: -2.47%
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $289.09
Upside: +48.74%
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $276.67
Upside: +15.66%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $135.68
Upside: +25.29%
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $77.21
Upside: -9.34%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $2.72
Upside: +451.47%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $5.53
Upside: +62.75%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $290.71
Upside: +34.15%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $184.99
Upside: +35.14%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $41.23
Upside: +91.61%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $344.78
Upside: +66.77%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $243.33
Upside: -26.03%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $4.56
Upside: +1,478.95%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $34.41
Upside: -68.03%